Where are we with the management of hypertension? From science to clinical practice

16Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

The management of elevated blood pressure in patients at high cardiovascular risk is still a subject of debate. The authors review current international guidelines and results of large clinical trials and recent meta-analyses to discuss the different approaches in patients at high risk for cardiovascular events. The different treatment options are considered in view of the modern approach and of the different classes of drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, β-blockers, and angiotensin II receptor blockers) currently in use. A case report is presented as an illustration of the difficulties related to the management of high blood pressure in patients at increased risk. The benefits of the use of 2 medications that include an inhibitor of the renin-angiotensin-aldosterone system and a calcium channel blocker or a diuretic are discussed. Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension. © 2009 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Farsang, C., Naditch-Brule, L., Avogaro, A., Östergren, J., Verdecchia, P., Maggioni, A., … Roca-Cusachs, A. (2009). Where are we with the management of hypertension? From science to clinical practice. Journal of Clinical Hypertension. https://doi.org/10.1111/j.1751-7176.2008.00066.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free